论文部分内容阅读
2013年12月,继原研药在山东基药市场全面溃败、多地招标质量层级被下调之后,中央层面又传出消息,称国家发展改革委计划取消药品单独定价。单独定价拟取消据一位卫计委政策研究专家透露,国家正在推动仿制药一致性评价,意在保护优质仿制药,“仿制药与原研药一致性评价无差别后,原研药则没有充分的依据继续单独定价,所以单独定价资格要取消”。
In December 2013, following the overall failure of the original research drug in the base drug market of Shandong Province and the downward adjustment of the bidding quality levels, the central authorities also came out with news that the NDRC plans to cancel the drug pricing alone. Individual pricing to be canceled According to a policy analyst said the National Development Planning Commission said the country is promoting generic drug consistency assessment, intended to protect high-quality generic drugs, “generic drugs and the original drug consistency assessment no difference, the original research drug is not sufficient The basis for the continued pricing alone, so separate qualifications to be canceled ”.